S&P 500
(-0.40%) 5 214.58 points

Dow Jones
(0.58%) 38 334 points

Nasdaq
(-1.28%) 16 522 points

Oil
(-0.95%) $77.17

Gas
(0.00%) $2.57

Gold
(-0.83%) $2 346.80

Silver
(-3.34%) $30.48

Platinum
(0.57%) $1 043.90

USD/EUR
(-0.11%) $0.922

USD/NOK
(-0.37%) $10.50

USD/GBP
(0.04%) $0.786

USD/RUB
(0.17%) $90.41

Realtime updates for Bafna Pharmaceuticals [BAFNAPH.NS]

Exchange: NSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Last Updated27 May 2024 @ 03:01

25% discount on Stockinvest.us - Use code: Podcast

0.00% INR 89.95

Live Chart Being Loaded With Signals

Commentary (27 May 2024 @ 03:01):

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets...

Stats
Today's Volume	1 810.00
Average Volume	5 831.00
Market Cap	2.13B
EPS	INR0 ( 2024-05-28 )
Next earnings date	( INR0 ) 2024-08-08
Last Dividend	INR0.600 ( 2013-09-19 )
Next Dividend	INR0 ( N/A )
P/E	18.82
ATR14	INR0 (0.00%)

Bafna Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bafna Pharmaceuticals Financials

Annual	2023
Revenue:	INR1.52B
Gross Profit:	INR215.36M (14.12 %)
EPS:	INR3.11

FY	2023
Revenue:	INR1.52B
Gross Profit:	INR215.36M (14.12 %)
EPS:	INR3.11

FY	2022
Revenue:	INR1.15B
Gross Profit:	INR387.56M (33.60 %)
EPS:	INR4.79

FY	2022
Revenue:	INR851.40M
Gross Profit:	INR338.55M (39.76 %)
EPS:	INR2.17

Financial Reports:

No articles found.

Bafna Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Bafna Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.63 - No dividend growth expected in the near future

Information

First Dividend	INR0.600	2013-09-19
Last Dividend	INR0.600	2013-09-19
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR0.600	--
Avg. Dividend % Per Year	0.00%	--
Score	2.07	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.63
Div. Directional Score	6.88	--

Next Divdend (Est)
(2024-05-31)

INR0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

2.07

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
SUNTV.NS	Dividend King	2023-08-22	Quarterly	19	1.94%
NAM-INDIA.NS	Dividend Knight	2023-06-29	Semi-Annually	7	2.04%
HGS.NS	Dividend Knight	2023-09-13	Quarterly	18	2.51%
BIKAJI.NS	Dividend Junior	2023-06-08	Insufficient data to determine frequency	2	0.06%
RITES.NS	Dividend King	2023-09-08	Quarterly	7	3.95%
KSOLVES.NS	Dividend Knight	2023-07-13	Semi-Annually	4	2.86%
ESTER.NS	Dividend Junior	2023-09-20	Sporadic	14	1.55%
ALKALI.NS	Dividend Knight	2023-08-14	Annually	16	1.21%
TDPOWERSYS.NS	Dividend Knight	2023-08-02	Annually	13	0.31%
NOVARTIND.NS	Dividend Knight	2023-07-20	Annually	4	2.07%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0482	1.500	9.04	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0498	1.200	8.34	10.00	[0 - 0.3]
returnOnEquityTTM	0.0921	1.500	-0.0874	-0.131	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.747	0.800	6.27	5.01	[1 - 3]
quickRatioTTM	0.867	0.800	9.61	7.69	[0.8 - 2.5]
cashRatioTTM	0.0258	1.500	-0.968	-1.452	[0.2 - 2]
debtRatioTTM	0.165	-1.500	7.25	-10.00	[0 - 0.6]
interestCoverageTTM	3.17	1.000	9.94	9.94	[3 - 30]
operatingCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.44	2.00	7.78	10.00	[0 - 20]
debtEquityRatioTTM	0.302	-1.500	8.79	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.255	1.000	9.08	9.08	[0.2 - 0.8]
operatingProfitMarginTTM	0.0476	1.000	-1.048	-1.048	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.430	1.000	8.72	8.72	[0.2 - 2]
assetTurnoverTTM	1.032	0.800	6.45	5.16	[0.5 - 2]
Total Score				10.13

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	28.96	1.000	7.18	0	[1 - 100]
returnOnEquityTTM	0.0921	2.50	-0.0562	-0.131	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.44	2.00	8.52	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.748	1.500	8.35	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0689	1.000	-0.778	0	[0.1 - 0.5]
Total Score				3.63

Bafna Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.

Total Execution Time: 1.8212299346924 seconds
Number of API calls: 2
Number of DB calls: 8